Quest Diagnostics IncorporatedDGXNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P28
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -26.73% |
| Q3 2025 | -3.90% |
| Q2 2025 | 121.32% |
| Q1 2025 | -42.23% |
| Q4 2024 | 36.40% |
| Q3 2024 | -6.72% |
| Q2 2024 | 436.00% |
| Q1 2024 | -89.01% |
| Q4 2023 | 346.08% |
| Q3 2023 | -70.00% |
| Q2 2023 | 1130.30% |
| Q1 2023 | -117.65% |
| Q4 2022 | -51.30% |
| Q3 2022 | 17.79% |
| Q2 2022 | -21.82% |
| Q1 2022 | 23.74% |
| Q4 2021 | -28.60% |
| Q3 2021 | 25.53% |
| Q2 2021 | -41.71% |
| Q1 2021 | 70.18% |
| Q4 2020 | -50.84% |
| Q3 2020 | 182.42% |
| Q2 2020 | 66.46% |
| Q1 2020 | -6.82% |
| Q4 2019 | -13.30% |
| Q3 2019 | -13.98% |
| Q2 2019 | 3.51% |
| Q1 2019 | 58.33% |
| Q4 2018 | -55.14% |
| Q3 2018 | 31.02% |
| Q2 2018 | 128.97% |
| Q1 2018 | -55.60% |
| Q4 2017 | -19.40% |
| Q3 2017 | 30.57% |
| Q2 2017 | 48.70% |
| Q1 2017 | -12.50% |
| Q4 2016 | -26.67% |
| Q3 2016 | -9.09% |
| Q2 2016 | 175.00% |
| Q1 2016 | -45.76% |